Skip to content

A cohort study of Gubi recipe in treating knee osteoarthritis with kidney deficiency and collateral obstruction syndrome

A cohort study of Gubi recipe in treating knee osteoarthritis with kidney deficiency and collateral obstruction syndrome

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ITMCTR
Registry ID
ITMCTR2200006079
Enrollment
Unknown
Registered
2022-06-07
Start date
2022-06-10
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

knee osteoarthritis

Interventions

Control Group:(Sulfuric acid or hydrochloric acid) glucosamine
Treatment Group:Gubi recipe

Sponsors

Jiangsu Province Hospital of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic criteria for knee osteoarthritis; 2. Meet the criteria of TCM syndrome diagnosis of kidney deficiency and collateral obstruction syndrome; 3.50 years = age =75 years, no gender limitation; 4. Visual Analogue Scale (VAS) score of knee pain: 2 =VAS=6; 5. Knee osteoarthritis Kellgren&Lawrence grade =?; 6. Patients voluntarily participated in the study, read and signed the informed consent.

Exclusion criteria

Exclusion criteria: 1. Other osteoarthritis patients, such as hip osteoarthritis, hand osteoarthritis, etc.; 2. Patients with secondary knee osteoarthritis caused by other diseases, such as joint trauma, congenital or genetic diseases, etc. 3. Patients with some serious primary diseases, such as digestive, respiratory, cardiovascular, hematopoietic and nervous system diseases, mental diseases, etc.; 4. Abnormal liver and kidney function, such as alanine aminotransferase (ALT) and aspartate aminotransferase (AST) exceeding 1.5 times the normal value, blood creatinine (Scr) and urea nitrogen (BUN) any higher than the normal value; 5. Patients who had received knee arthrocentesis during recent 6 months; 6. Allergic constitution and allergic to clinical study medication; 7. Women who are during pregnancy, preparing for pregnancy, or during breastfeeding period.

Design outcomes

Primary

MeasureTime frame
Western Ontario and McMaster University Osteoarthritis Index score;

Secondary

MeasureTime frame
TCM syndrome integral;Lequesne;VAS;

Countries

China

Contacts

Public ContactLiang Fang

Jiangsu Province Hospital of Chinese Medicine

fl@njucm.edu.cn13952089209

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026